Cannabis Stocks Soar: DEA Reclassifies Cannabis As Schedule III Drug

The United States is on the brink of a monumental shift in its policy towards marijuana, a change that could redefine the nation’s stance on one of its most debated substances. The Drug Enforcement Administration (DEA) has put forward a proposal to reclassify marijuana as a less harmful drug, a move that has energized the cannabis industry and sparked significant activity in the stocks of companies involved in this sector. This long-overdue policy shift recognizes the medical uses of cannabis and its lower potential for abuse compared to some of the nation's most dangerous drugs. But what does this mean for the future of cannabis in the U.S., and how does it affect the legal, economic, and social landscape? $Innovative Industrial Properties Inc (IIPR.US)$